Insights and progress on postoperative analgesia of radical gastrectomy for gastric cancer: a comprehensive review.
Gastric cancer is a common and highly lethal malignancy of the digestive system, with surgical resection as the primary treatment approach.
APA
Li L, Zhao Y, et al. (2025). Insights and progress on postoperative analgesia of radical gastrectomy for gastric cancer: a comprehensive review.. Frontiers in pain research (Lausanne, Switzerland), 6, 1601220. https://doi.org/10.3389/fpain.2025.1601220
MLA
Li L, et al.. "Insights and progress on postoperative analgesia of radical gastrectomy for gastric cancer: a comprehensive review.." Frontiers in pain research (Lausanne, Switzerland), vol. 6, 2025, pp. 1601220.
PMID
40661976
Abstract
Gastric cancer is a common and highly lethal malignancy of the digestive system, with surgical resection as the primary treatment approach. However, postoperative analgesia management remains a major clinical challenge. Postoperative pain not only affects recovery speed but may also lead to complications, thereby influencing prognosis. Recent research on postoperative pain following gastric cancer surgery has expanded, exploring various analgesic methods, including pharmacological therapy, neuraxial blocks, and non-pharmacological approaches, with growing emphasis on individualized analgesia protocols. Despite the proposal of multiple analgesic techniques, current research indicates that their effectiveness and safety are still inadequately assessed in clinical applications. This review aims to discuss the physiological mechanisms of postoperative pain following gastric cancer surgery, modern analgesic strategies, and related research, to provide a theoretical basis and clinical guidance for improving postoperative quality of life.
같은 제1저자의 인용 많은 논문 (5)
- The Role of Probiotics , , and in Inhibziting Pathogens, Maintaining Gut Health, and Improving Disease Outcomes.
- Ziyuglycoside II ameliorates chemotherapy-induced neutropenia by promoting neutrophil differentiation and functional recovery via SPI1 and C/EBPϵ transcriptional regulation.
- Tumor-specific glyco-detonators: A neuraminidase-3-gated programmable DNA Nanoarchitectonics for liver cancer-exclusive chemotherapy.
- Absence of independent prognostic impact of node status in M1 prostate cancer: implications from a SEER-based study.
- Correction: Let-7b-5p inhibits breast cancer cell growth and metastasis via repression of hexokinase 2-mediated aerobic glycolysis.